The U.S. government efforts to shore up global health security face a time of transition. The U.S. has played a leadership role in the Global Health Security Agenda (GHSA), which is entering its next phase, and the increase in funding after the Ebola and Zika outbreaks allowed for the expansion of U.S. efforts around the world. However, this funding is slated to run out by the end of FY 2019, just as the GHSA looks to begin its second five year period. What is the future of U.S. engagement in global health security, including funding levels and programmatic support? What role will the U.S. play in the GHSA in the coming years? How do global health security efforts fit within the broader context of U.S. global health work?

On Monday, March 12 the Kaiser Family Foundation held an event to explore these and other questions on the future of U.S. global health security efforts with a panel of leading experts.

Jen Kates, Vice President and Director of Global Health and HIV Policy, provided opening remarks, and Anne Schuchat, Acting Director, Centers for Disease Control and Prevention (CDC), gave a keynote address on U.S. global health security efforts.

Josh Michaud, Associate Director of Global Health Policy at the Kaiser Family Foundation, moderated a follow up discussion with Beth Cameron, Vice President for Global Biological Policy and Programs at the Nuclear Threat Initiative (NTI); Rebecca Katz, Associate Professor and Co-Director of the Center for Global Health Science and Security at Georgetown University; Nancy Knight, Director of the Division of Global Health Protection at CDC; and J. Stephen Morrison, Senior Vice President and Director of the CSIS Global Health Policy Center.